At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
HCC Warrior Met Coal LLC
Closed Independence Day 07-02 16:00:00 EDT
80.83
+2.57
+3.28%
盘后82.08
+1.25+1.55%
19:54 EDT
High81.93Low78.80Vol879.83K
Open78.80D1 Closing78.26Amplitude4.00%
Mkt Cap4.25BTradable Cap4.16BTotal Shares52.57M
T/O70.40MT/O Rate1.71%Tradable Shares51.47M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

Can-Fite Phase 2a Pancreatic Cancer Study with Namodenoson Achieves Primary Safety Endpoint and Demonstrates Durable Survival Outcomes in Advanced Disease
GlobeNewswire  ·  07-01 19:00
Can-Fite Phase 2a Pancreatic Cancer Study with Namodenoson Achieves Primary Safety Endpoint and Demonstrates Durable Survival Outcomes in Advanced Disease
3 US Manufacturing Stocks Tied To Onshoring And Trade Tariff Shifts
Simply Wall St.  ·  07-01 15:39
3 US Manufacturing Stocks Tied To Onshoring And Trade Tariff Shifts
Warrior Met Coal is Maintained at Buy by UBS
Dow Jones  ·  07-01 03:20
Warrior Met Coal is Maintained at Buy by UBS
UBS Adjusts Price Target on Warrior Met Coal to $100 From $102, Maintains Buy Rating
MT Newswires Live  ·  06-30 21:13
UBS Adjusts Price Target on Warrior Met Coal to $100 From $102, Maintains Buy Rating
UBS Keeps Their Buy Rating on Warrior Met Coal (HCC)
TIPRANKS  ·  06-30 20:35
UBS Keeps Their Buy Rating on Warrior Met Coal (HCC)
Can-Fite Secures Japanese Patent Allowance for Namodenoson's Anti-Obesity Technology
GlobeNewswire  ·  06-26
Can-Fite Secures Japanese Patent Allowance for Namodenoson's Anti-Obesity Technology
HENLIUS Announces First US Patient Dosed in Global Phase 1 Trial for HLX13, an Ipilimumab Biosimilar, in First-Line Unresectable Advanced Liver Cancer
Stock News  ·  06-25
HENLIUS Announces First US Patient Dosed in Global Phase 1 Trial for HLX13, an Ipilimumab Biosimilar, in First-Line Unresectable Advanced Liver Cancer
SQM Stock And 2 Global Exporters For Investors Looking Beyond Tech
Simply Wall St.  ·  06-24
SQM Stock And 2 Global Exporters For Investors Looking Beyond Tech
Warrior Met Coal’s (HCC) Insider Sales Amid Rich Valuation: What Do They Signal About Risk‑Reward?
Simply Wall St.  ·  06-24
Warrior Met Coal’s (HCC) Insider Sales Amid Rich Valuation: What Do They Signal About Risk‑Reward?
Can-Fite Publishes Peer-Reviewed Scientific Article Demonstrating the Broad Therapeutic Potential of Piclidenoson and Namodenoson
GlobeNewswire  ·  06-22
Can-Fite Publishes Peer-Reviewed Scientific Article Demonstrating the Broad Therapeutic Potential of Piclidenoson and Namodenoson
Can-Fite to Present Late-Stage Clinical Pipeline and Licensing Opportunities at BIO International Convention 2026
GlobeNewswire  ·  06-17
Can-Fite to Present Late-Stage Clinical Pipeline and Licensing Opportunities at BIO International Convention 2026
Warrior Met Coal Is Maintained at Buy by B. Riley Securities
Dow Jones  ·  06-11
Warrior Met Coal Is Maintained at Buy by B. Riley Securities
Warrior Met Coal Inc : B. Riley Raises Target Price to $123 From $117
THOMSON REUTERS  ·  06-10
Warrior Met Coal Inc : B. Riley Raises Target Price to $123 From $117
B. Riley Raises Price Target on Warrior Met Coal to $123 From $117, Keeps Buy Rating
MT Newswires Live  ·  06-10
B. Riley Raises Price Target on Warrior Met Coal to $123 From $117, Keeps Buy Rating
Warrior Met Coal Chief Administrative Officer Kelli K. Gant sells 20,000 shares for $2.2 million
Reuters  ·  06-05
Warrior Met Coal Chief Administrative Officer Kelli K. Gant sells 20,000 shares for $2.2 million
RBC Capital Reaffirms Their Hold Rating on Warrior Met Coal (HCC)
TIPRANKS  ·  06-04
RBC Capital Reaffirms Their Hold Rating on Warrior Met Coal (HCC)
ABBISKO-B Presents Innovative Modeling Framework for ABSK-011 in HCC at PAGE Conference
Stock News  ·  06-04
ABBISKO-B Presents Innovative Modeling Framework for ABSK-011 in HCC at PAGE Conference
Chinese Coal-Mine Disruptions Could Be Major Supply Shock for Global Markets -- Market Talk
Dow Jones  ·  05-28
Chinese Coal-Mine Disruptions Could Be Major Supply Shock for Global Markets -- Market Talk
Junshi Biosciences Announces Primary Endpoints Met in Final Analysis of Phase 3 Study for Perioperative Toripalimab plus Chemotherapy for Resectable Stage II-III NSCLC
GlobeNewswire  ·  05-27
Junshi Biosciences Announces Primary Endpoints Met in Final Analysis of Phase 3 Study for Perioperative Toripalimab plus Chemotherapy for Resectable Stage II-III NSCLC
Assessing Warrior Met Coal (HCC) Valuation After Recent Share Price Softness And Blue Creek Growth Plans
Simply Wall St.  ·  05-27
Assessing Warrior Met Coal (HCC) Valuation After Recent Share Price Softness And Blue Creek Growth Plans

Introduction

Company Name.
Warrior Met Coal LLC
Affiliated Markets:
NYSE
Listing Date:
--
Main Business:
Warrior Met Coal, Inc. produces and exports non-thermal metallurgical coal for the steel industry. It operates two underground mines located in Alabama. The company sells its metallurgical coal to a customer base of blast furnace steel producers located primarily in Europe, South America, and Asia. It also sells natural gas, which is extracted as a byproduct from coal production. Warrior Met Coal, Inc. was incorporated in 2015 and is headquartered in Brookwood, Alabama.
Issue price:
--